Grail (GRAL) Other financing activities (2023 - 2024)

Grail's (GRAL) quarterly Other financing activities came in at $932.3 million in Q2 2024, up 198.81% on a QoQ basis from $312.0 million in Q1 2024.

Grail (GRAL) Other financing activities (2023 - 2024) Analysis & Trends

Grail (GRAL) has 2 years of Other financing activities data on file, last reported at $932.3 million in Q2 2024.

Quarterly Other financing activities changed N/A year-over-year to $932.3 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $932.3 million (changed N/A YoY) and the FY2024 annual result came in at $1.2 billion, up 168.17% from the prior year.
Other financing activities improved to $932.3 million in Q2 2024, from $312.0 million in the prior quarter.
In the past five years, Other financing activities ranged from a high of $932.3 million in Q2 2024 to a low of $86.0 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn
10	Grail	3.01 Bn	2.19 Bn	19.54 Mn

Download Data